AXNX
Axonics Modulation Technologies Inc
NASDAQ: AXNX · HEALTHCARE · MEDICAL DEVICES
$0.43
-12.47% today
Updated 2026-10-20
Market cap
$3.63B
P/E ratio
—
P/S ratio
8.40x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $0
Volume
0.5M
WallStSmart proprietary scores
36
out of 100
Grade: D
Sell
Investment rating
9.3
Growth
A+9.0
Quality
A+2.8
Profitability
F5.0
Valuation
C+5/9
Piotroski F-Score
Moderate
5.1
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$72.00
+16683.22%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 5.14 — safe zone
+ Revenue growth 24.80% QoQ
+ Debt/equity 0.05x — low leverage
Risks
- Thin margins at -1.31%
- Negative free cash flow $-2.40M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Revenue | $111.53M | $180.29M | $273.70M | $366.38M | $431.90M |
| Net income | $-54.91M | $-80.07M | $-59.70M | $-6.09M | $-21000.00 |
| EPS | — | — | — | — | $-0.10 |
| Free cash flow | $-86.68M | $-49.57M | $968000.00 | $-5.57M | $-2.40M |
| Profit margin | -49.24% | -44.41% | -21.81% | -1.66% | -1.31% |
Peer comparison
Smart narrative
Axonics Modulation Technologies Inc trades at $0.43. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 5.14, it sits in the safe zone. TTM revenue stands at $431.90M. with profit margins at -1.31%.
Frequently asked questions
What is Axonics Modulation Technologies Inc's stock price?
Axonics Modulation Technologies Inc (AXNX) trades at $0.43, on a P/S of 8.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Axonics Modulation Technologies Inc overvalued?
Axonics Modulation Technologies Inc carries a Smart Value Score of 36/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Axonics Modulation Technologies Inc (AXNX)?
The 12-month analyst consensus target is $72.00, about 16683.2% above the current $0.43. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Axonics Modulation Technologies Inc's revenue?
Axonics Modulation Technologies Inc's trailing twelve-month revenue is $431.90M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Axonics Modulation Technologies Inc's Altman Z-Score is 5.14, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio8.40x
ROE—
Beta0.83
50D MA$69.87
200D MA$68.38
Shares out0.05B
Float0.05B
Short ratio—
Avg volume0.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—